Personalized and predictive medicine is revolutionizing healthcare and life science start-ups are its key accelerators. BioConAct is happy to contribute.
Healthcare key accelerators
Technological innovations in life sciences introduce a new era of healthcare.
Today, DNA-sequences and protein biomarkers can tell us whether an individual is developing/will develop an illness and how he/she will respond to treatment. Immunotherapy holds tremendous potential as both cancer treatment and vaccination. Moreover, the trend to live longer and healthier is supported by healthcare apps and wearables.
This shift towards personalized and predictive medicine is revolutionizing healthcare. Nextgen sequencing, ‘Omics’ sciences, immunotherapy, companion diagnostics, 3D printing, new imaging technologies, artificial intelligence, nano technologies and big data are the new cornerstones.
The role of BioConAct
This revolution harbours the potential to improve treatments and people’s lives and to reduce overall healthcare costs. That’s why we need to generate a steady stream of innovations by encouraging life science entrepreneurs to bring them to market.
BioConAct takes care of the entire commercial process for start-ups and scale-ups, creating added value for founders, employees, investors and end clients. A win-win situation!
What about you? How can I help?
Whether you’re the founder of a life sciences start-up, manager of a scale-up, or a current or potential investor, I know the challenges you face. During the course of an exploratory conversation, I’ll listen to what you need, and collaborate with you. Of course, I will only come on board if we believe in one another.